109 related articles for article (PubMed ID: 12447651)
1. [Opportunities and chances for tissue chip microarrays in head and neck surgery. A novel technique for the rapid evaluation of potentially novel biomarkers].
Hofele C; Joos S; Flechtenmacher C; Bosch FX; Lichter P; Mühling J; Freier K
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):394-401. PubMed ID: 12447651
[TBL] [Abstract][Full Text] [Related]
2. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
Suzuki H; Sugimura H; Hashimoto K
J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
[TBL] [Abstract][Full Text] [Related]
3. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas.
Liu CJ; Lin SC; Chen YJ; Chang KM; Chang KW
Mol Carcinog; 2006 Oct; 45(10):721-31. PubMed ID: 16676365
[TBL] [Abstract][Full Text] [Related]
4. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
5. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
[TBL] [Abstract][Full Text] [Related]
6. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
[TBL] [Abstract][Full Text] [Related]
7. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
8. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
9. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.
Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T
Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
[TBL] [Abstract][Full Text] [Related]
12. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
13. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional expression profiles of oral squamous cell carcinomas.
Méndez E; Cheng C; Farwell DG; Ricks S; Agoff SN; Futran ND; Weymuller EA; Maronian NC; Zhao LP; Chen C
Cancer; 2002 Oct; 95(7):1482-94. PubMed ID: 12237917
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers in oral epithelial dysplasia: review.
Pitiyage G; Tilakaratne WM; Tavassoli M; Warnakulasuriya S
J Oral Pathol Med; 2009 Nov; 38(10):737-52. PubMed ID: 19903246
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in oral squamous cell carcinoma progression detected by combining array-based comparative genomic hybridization and multiplex ligation-dependent probe amplification.
Cha JD; Kim HJ; Cha IH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):594-607. PubMed ID: 21334929
[TBL] [Abstract][Full Text] [Related]
18. Disease mechanism and biomarkers of oral squamous cell carcinoma.
Brinkman BM; Wong DT
Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
[TBL] [Abstract][Full Text] [Related]
19. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
20. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).
Freier K; Schwaenen C; Sticht C; Flechtenmacher C; Mühling J; Hofele C; Radlwimmer B; Lichter P; Joos S
Oral Oncol; 2007 Jan; 43(1):60-6. PubMed ID: 16807070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
